Later this month, members of the US House of Representatives were expected to vote for the first time on a bill to legalize marijuana

Later this month, members of the US House of Representatives were expected to vote for the first time on a bill to legalize marijuana, marking a significant milestone in the history of marijuana reform. There are many marijuana-related reform bills pending in Congress, but The Marijuana Opportunity, Reinvestment, and Expungement Act (aka The MORE Act) that Congress was set to vote on in late September, is the most significant and comprehensive marijuana reform bill pending; decriminalizing marijuana and making several changes to the marijuana policy on a federal level.

What makes this bill so significant?  “The MORE Act would actually erase past convictions for marijuana offenses, opening the door to opportunities to jobs, housing, education, things that could help people, but it would also make it so people will no longer be denied federal benefits because of marijuana activity,” said Maritza Perez, Director of the Drug Policy Alliance (i).

Specifically, The MORE Act removes marijuana from the list of scheduled substances under the Controlled Substances Act and eliminates criminal penalties for an individual who manufactures, distributes, or possesses marijuana (ii).

The bill also makes other changes, including the following:

  • replaces statutory references to marijuana and marihuana with cannabis,

  • requires the Bureau of Labor Statistics to regularly publish demographic data on cannabis business owners and employees,

  • establishes a trust fund to support various programs and services for individuals and businesses in communities impacted by the war on drugs,

  • imposes a 5% tax on cannabis products and requires revenues to be deposited into the trust fund,

  • makes Small Business Administration loans and services available to entities that are cannabis-related legitimate businesses or service providers,

  • prohibits the denial of federal public benefits to a person on the basis of certain cannabis-related conduct or convictions,

  • prohibits the denial of benefits and protections under immigration laws on the basis of a cannabis-related event (e.g., conduct or a conviction), and

  • establishes a process to expunge convictions and conduct sentencing review hearings related to federal cannabis offenses.

Despite widespread support of The MORE Act from legalization advocates, the House has decided to postpone the much-anticipated vote until late Fall 2020.  “Right now, the House is focused relentlessly on securing agreement to stave off a damaging government shutdown and continuing to do its job addressing the COVID-19 pandemic,” House Majority Leader Steny H. Hoyer said in a statement (iii).

Supporters of The More Act are disappointed the House leaders have reversed their previously announced plan, but they remain hopeful that marijuana reform will continue to have momentum, and that after the election in November, the bill will be revisited. In the meantime, we’ll be following this topic closely, so stay tuned here for updates.

 

SOURCES:
(i) https://www.10news.com/news/national/for-first-time-house-will-vote-on-bill-that-would-legalize-marijuana-on-federal-level?fbclid=IwAR0Ai0TGkyOKdUqg8O0pSemMwegGxGOzMLaS2dahWgQBaNougFIrI227ui8
(ii) https://www.congress.gov/bill/116th-congress/senate-bill/2227
(iii) https://hightimes.com/news/congress-delays-vote-more-act/
(iiii) https://www.marijuanamoment.net/house-to-vote-on-historic-marijuana-legalization-bill-next-month-leadership-announces/

DISCLAIMER:
The information provided by Health for Life, its parents or affiliates (“we,” “us” or “our”) on www.healthforlifedispensaries.com (the “Site”), including this Blog, is for general informational purposes only. All information on the Site is provided in good faith, however we make no representation or warranty of any kind, express or implied, regarding the accuracy, adequacy, validity, reliability, availability or completeness of any information on the Site.  The views and opinions expressed in this Blog are those of the authors and do not necessarily our official policy or position of any other agency, organization, employer or company. Assumptions made in the blogs are not reflective of the position of any entity other than the author(s) – these views are always subject to change, revisions, and updates at any time. There is no obligation to purchase any product mentioned. The Site may contain (or you may be sent through the Site links to other websites or content belonging to or originating from third parties or links to websites and features in banners or other advertising. Such external links are not investigated, monitored, or checked for accuracy, adequacy, validity, reliability, availability or completeness by us.  We do not warrant, endorse, guarantee, or assume responsibility for the accuracy or reliability of any information offered by third-party websites linked through the site or any website or feature linked in any banner or other advertising. We will not be a party to or in any way be responsible for monitoring any transaction between you and third-party providers of products or services.  The Site cannot and does not contain medical or health advice. The medical or health information is provided for general informational and educational purposes only and is not a substitute for professional advice.  Accordingly, before taking any actions based upon such information, we encourage you to consult with the appropriate professionals. We do not provide any kind of medical or health advice. The use or reliance of any information contained on this site is solely at your own risk.

Facebook Comments

Post comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Skip to content